In contrast, Cbl-c has a shorter proline-rich region and lacks a UBA domain.41 The significance of the Cbl family in regulating the response to ICB treatment lies in the notion that they are capable of regulating PD-1/PD-L1 expression in cancers (Fig. 2). The gene discussed is CD274; the disease is cancer.